Methylphenidate Teva Description

18 mg tablet: Each prolonged-release tablet contains 18 mg of methylphenidate hydrochloride equivalent to 15.6 mg of methylphenidate.
27 mg tablet: Each prolonged-release tablet contains 27 mg of methylphenidate hydrochloride equivalent to 23.3 mg of methylphenidate.
36 mg tablet: Each prolonged-release tablet contains 36 mg of methylphenidate hydrochloride equivalent to 31.1 mg of methylphenidate.
54 mg tablet: Each prolonged-release tablet contains 54 mg of methylphenidate hydrochloride equivalent to 46.7 mg of methylphenidate.
Excipients/Inactive Ingredients: Tablet core: Lactose monohydrate (spray dried), hypromellose (K100 LV), colloidal anhydrous silica, magnesium stearate, methacrylic acid-methyl methacrylate copolymer (1:1), methacrylic acid-methyl methacrylate copolymer (1:2), triethyl citrate, talc, acetone, isopropyl alcohol, hypromellose (E5 LV), fumaric acid, water.
Tablet coating: 18 mg tablet: Polyvinyl alcohol-part. hydrolyzed, Macrogol/PEG (3350), talc, titanium dioxide (E171), iron oxide yellow (E172), iron oxide red (E172), water.
27 mg tablet: Polyvinyl alcohol-part. hydrolyzed, Macrogol/PEG (3350), talc, titanium dioxide (E171), FD&C Blue #2/Indigo carmine aluminium lake (E132), iron oxide black (E172), iron oxide yellow (E172), water.
36 mg tablet: Polyvinyl alcohol-part. hydrolyzed, Macrogol/PEG (3350), talc, titanium dioxide (E171), water.
54 mg tablet: Polyvinyl alcohol-part. hydrolyzed, Macrogol/PEG (3350), talc, titanium dioxide (E171), iron oxide red (E172), water.
Printing ink: Shellac glaze, isopropyl alcohol, iron oxide black (E172), N-butyl alcohol, propylene glycol, ammonium hydroxide 28%.